TLT Longevity
Scaling the infrastructure for enduring life.
Life sciences and longevity infrastructure.
TLT Longevity I
Select investment
The intelligent building platform enabling net-zero living anywhere, combining sustainability with rapid infrastructure.
TLT Longevity II
Select investment
A biotechnology platform targeting the molecular drivers of neurological injury and systemic structural decline.
Related-party disclosure: Michael Brown, Managing Director of TLT Capital, is a co-founder and equity holder of LongTermGevity. This relationship is disclosed here in the interest of transparency with prospective and existing investors.
No offer or solicitation of securities. This page is meant for informational purposes only and does not constitute an offer to sell or buy any security in any jurisdiction.